Category: <span>first line treatment for mesothelioma</span>

Category: first line treatment for mesothelioma

chemotherapy clinical trial, chemotherapy for mesothelioma, doctor shirish gadgeel, first line treatment for mesothelioma, Human Investigation Committee at Wayne State, mesothelioma diagnosis, Mesothelioma News, peritoneal mesothelioma, treatment for mesothelioma, wayne state university

Study Shows Impact of Chemotherapy on Mesothelioma

 

A U.S.-based study confirms what oncology experts have suggested for years — chemotherapy treatment prolongs life expectancy for malignant mesothelioma patients. Wayne State University School of Medicine researchers linked data from the National Cancer Institute’s Surveillance, Epidemiology and End Results (SEER) database with Medicare claims data. The study took into account patient characteristics such as…

The post Study Shows Impact of Chemotherapy on Mesothelioma appeared first on Mesothelioma Center – Vital Services for Cancer Patients & Families.

clinical trials for mesothelioma, first line treatment for mesothelioma, immunotherapy for mesothelioma, Keytruda, Mesothelioma News, Pembrolizumab, pleural mesothelioma treatment

Using Keytruda for Mesothelioma May Become a Reality

 

The U.S. Food and Drug Administration recently upgraded its approval of pembrolizumab (Keytruda) for metastatic non-small cell lung cancer, inching it closer to becoming an accepted treatment option for pleural mesothelioma. Pembrolizumab, produced by pharmaceutical giant Merck & Co., also is marketed as Keytruda. The FDA’s announcement last week converted its previous “accelerated” approval in…

The post Using Keytruda for Mesothelioma May Become a Reality appeared first on Mesothelioma Center – Vital Services for Cancer Patients & Families.